| Q37718215 | A piRNA-like Small RNA Induces Chemoresistance to Cisplatin-Based Therapy by Inhibiting Apoptosis in Lung Squamous Cell Carcinoma |
| Q34770842 | A small nuclear RNA, hdm365, is the major processing product of the human mdm2 gene |
| Q40954121 | Activation of an MDM2-specific caspase by p53 in the absence of apoptosis |
| Q28165459 | Activation of p53 signalling in acetylsalicylic acid‐induced apoptosis in OC2 human oral cancer cells |
| Q43630489 | Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells |
| Q24310683 | Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop |
| Q24531676 | Caspase-mediated cleavage of eukaryotic translation initiation factor subunit 2alpha |
| Q102369259 | Comprehensive assessment of TP53 loss of function using multiple combinatorial mutagenesis libraries |
| Q39640414 | Cotranscriptional exon skipping in the genotoxic stress response |
| Q38961549 | Curcumin homing to the nucleolus: mechanism for initiation of an apoptotic program |
| Q55340354 | Decomposing the Apoptosis Pathway Into Biologically Interpretable Principal Components. |
| Q73044244 | Deregulation of Cdc2 kinase induces caspase-3 activation and apoptosis |
| Q40783221 | Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. |
| Q36289902 | Differential regulation of p21 (waf1) protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implications |
| Q33739319 | Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis |
| Q40796996 | Exploitation of a non-apoptotic caspase to regulate the abundance of the cdkI p27(KIP1) in transformed lymphoid cells |
| Q38705008 | HIV-1 Tat potently stabilises Mdm2 and enhances viral replication |
| Q55311618 | Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity. |
| Q35641639 | Human MDM2 isoforms translated differentially on constitutive versus p53-regulated transcripts have distinct functions in the p53/MDM2 and TSG101/MDM2 feedback control loops |
| Q30987442 | Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression |
| Q37278373 | MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02. |
| Q28200748 | MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts |
| Q39207567 | Murine double minute 2 as a modulator of retroviral restrictions mediated by TRIM5alpha |
| Q39594325 | NSP 5a3a: a potential novel cancer target in head and neck carcinoma |
| Q92143470 | Oridonin induces Mdm2-p60 to promote p53-mediated apoptosis and cell cycle arrest in neuroblastoma |
| Q52121428 | Overexpression of mouse Mdm2 induces developmental phenotypes in Drosophila. |
| Q40476066 | Progesterone inhibition of MDM2 p90 protein in MCF-7 human breast cancer cell line is dependent on p53 levels. |
| Q33892839 | Regulation of p53 stability and activity in response to genotoxic stress. |
| Q37177557 | Structurally novel steroidal spirooxindole by241 potently inhibits tumor growth mainly through ROS-mediated mechanisms |
| Q95301002 | Tau affects P53 function and cell fate during the DNA damage response |
| Q37787401 | The E2F1/Rb and p53/MDM2 Pathways in DNA Repair and Apoptosis: Understanding the Crosstalk to Develop Novel Strategies for Prostate Cancer Radiotherapy |
| Q55043013 | The HA tag is cleaved and loses immunoreactivity during apoptosis. |
| Q33427843 | The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome |
| Q53193985 | Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed. |
| Q90462955 | Zinc deficiency causes neural tube defects through attenuation of p53 ubiquitylation |
| Q40871184 | p27KIP1 is down-regulated by two different mechanisms in human lymphoid cells undergoing apoptosis |
| Q35871217 | p53 and MDM2 are involved in the regulation of osteocalcin gene expression. |
| Q40554202 | p53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2/MAPK. |